Watson David O. - 17 Jan 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
David Watson
Issuer symbol
APLS
Transactions as of
17 Jan 2025
Net transactions value
-$65,938
Form type
4
Filing time
21 Jan 2025, 16:14:27 UTC
Previous filing
14 Jan 2025
Next filing
23 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $65,938 -2,201 -2% $29.96 105,555 17 Jan 2025 Direct F1
transaction APLS Common Stock Award $0 +42,762 +41% $0.000000 148,317 21 Jan 2025 Direct F2
holding APLS Common Stock 3,333 17 Jan 2025 Indirect Owner (Custodial Account for Son) F3
holding APLS Common Stock 70,136 17 Jan 2025 Indirect Owner (The David O. Watson Irrevocable Trust of 2023) F4
holding APLS Common Stock 6,667 17 Jan 2025 Indirect Owner (The Watson Education Trust) F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2025.
F2 This represents a Restricted Stock Unit award granted on January 21, 2025 that vest 25% annually over four years from grant date subject to continued service.
F3 This represents a custodial account held by the reporting person for the sole benefit of his minor son.
F4 The securities are held by The David O. Watson Irrevocable Trust of 2023. William Zorn is the trustee of The David O. Watson Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The David O. Watson Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F5 The securities are held by The Watson Education Trust (the "Trust"), for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Trust except to the extent of his pecuniary interest therein.